Clomiphene Citrate
Mixed SERM used to stimulate endogenous gonadotropin release
Mechanism of Action
Clomiphene is a triphenylethylene SERM consisting of two stereoisomers (zuclomiphene and enclomiphene). It acts as a competitive antagonist at hypothalamic estrogen receptors, blocking negative feedback of circulating estradiol on the hypothalamic-pituitary axis. This disinhibition increases gonadotropin-releasing hormone (GnRH) pulsatility, stimulating pituitary LH and FSH release, which in turn stimulates gonadal steroidogenesis and spermatogenesis. Enclomiphene (trans-isomer) is the more active isomer for ovulation induction. In research contexts, clomiphene is studied for post-cycle HPTA recovery and hypogonadism.
Evidence Chain
Clomiphene Citrate
COMPOUND
1 Research Goal
• Sexual Health & Libido
Evidence Strength
4 articles sourced
Knowledge Graph
(5 connections)Research Goals
(1)Research Evidence
(4)Clomiphene Citrate: Evidence-Based Research Review
Clomiphene citrate (CC) is a non-steroidal triphenylethylene derivative classified as a Selective Estrogen Receptor Modulator (SERM). Originally developed for the induction of ovulation in women with anovulatory infertility, it has become a cornerstone of reproductive medicine. CC operates as a race
Raloxifene: Evidence-Based Research Review
Raloxifene is a second-generation selective estrogen receptor modulator (SERM) of the benzothiophene class. Developed to address the limitations of first-generation SERMs like tamoxifen, raloxifene exhibits distinct tissue-specific effects: it acts as an estrogen receptor (ER) agonist in bone and li
Tamoxifen vs Clomiphene: Evidence-Based Comparison
Tamoxifen Citrate and Clomiphene Citrate are triphenylethylene-derivative Selective Estrogen Receptor Modulators (SERMs) that have been used extensively in clinical practice for over four decades. While both compounds share a similar chemical backbone, they exhibit distinct tissue-specific activitie
Drostanolone Propionate: Evidence-Based Research Review
Drostanolone propionate (2α-methyl-5α-androstan-17β-ol-3-one propionate) is a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Originally developed for the treatment of advanced breast cancer in postmenopausal women, it is characterized by its inability to aromatiz
Related Compounds
Synergy & Compatibility
(5)Computational assessment of bio-regulatory compatibility with compounds sharing research goals. Scores reflect half-life alignment, receptor target overlap, and bioavailability data.
Highest Compatibility
Clomiphene Citrate + Toremifene Citrate
High Compatibility
Shared targets: estrogen receptor alpha (erα), estrogen receptor beta (erβ)
Shared targets: estrogen receptor alpha (erα), estrogen receptor beta (erβ)
Computational assessment based on available pharmacology data. Does not account for individual variability, dose-dependent effects, or unstudied interactions. For research use only.
Community Observations
(0)Qualitative, self-reported researcher observations. Distinct from peer-reviewed evidence — not medical advice.
No approved observations yet. Sign in to contribute.
For research use only. Not medical advice.